ArticleTrials2021

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.

I García-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.